About Deep Genomics
Deep Genomics is a leading artificial intelligence (AI) therapeutics company that is revolutionizing drug discovery and development for genetic diseases. The company leverages a proprietary AI-powered discovery platform, known as the AI Workbench, which integrates machine learning algorithms with vast genomic data. This platform allows Deep Genomics to analyze billions of predictions across the human genome, for millions of genetic variants, and hundreds of millions of novel compounds, a level of productivity unattainable through traditional methods.
Deep Genomics’ core focus is on decoding RNA biology to identify novel therapeutic targets and develop innovative RNA-based treatments. Their technology helps accelerate the early stages of drug discovery and the design of RNA-based therapies, including oligonucleotides, RNA editing, and mRNA. They aim to develop precision therapies tailored to individual genetic profiles, with an initial focus on central nervous system (CNS) and metabolic diseases.
Focus Areas
Business Intelligence
| Technology | BioFM Platform (Biological Foundation Models), AI Workbench, BigRNA (proprietary BioFM) |
What Physicians Need to Know
Deep Genomics' AI-driven platform, particularly their BioFM Platform and BigRNA model, offers physicians the potential for genetically precise therapies for diseases currently without cures. Their approach can lead to faster identification of drug candidates and a higher preclinical success rate compared to traditional methods. This means a future with more targeted and effective treatment options for patients with genetic, metabolic, and neurological conditions, including rare diseases. The ability of their SBOs to both increase and decrease gene expression provides a versatile therapeutic approach. Physicians can anticipate a growing pipeline of AI-discovered RNA therapies addressing the root genetic causes of diseases.
Deep Genomics' platform, including the AI Workbench and BioFM Platform, is designed to integrate AI, software engineering, and RNA biology. They also offer GenomeKit, a tool to streamline genomic sequence analysis for researchers. Their strategy includes strategic partnerships with pharmaceutical companies to accelerate the R&D process and translate AI insights into viable therapeutics. Their technology stack includes Kubeflow, NetSuite, Keras, Microsoft Windows, Bash, Microsoft Azure, C++, and Python.
Videos
News, demos, and interviews about Deep Genomics.
Videos load interactively. If none appear, search YouTube for Deep Genomics →
Frequently Asked Questions
Investors
Who's funded Deep Genomics.
Related Companies
ClinicalTrials.gov is a publicly accessible website and online database of clinical research studies, managed by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). It serves as a central resource for patients, their families, healthcare professionals, and researchers to access comprehensive information on publicly and privately supported clinical studies across a […]
InsightRX is a science-first company that develops AI-powered precision medicine software for healthcare providers and life sciences organizations. Founded in 2015 by pharmacometricians, the company’s core mission is to optimize drug dosing for individual patients, moving beyond a ‘one-size-fits-all’ approach. Their platform integrates patient-specific data, quantitative pharmacology models, and machine learning to provide individualized dosing […]
Indica Labs is a global leader in AI-powered digital pathology software and services, providing comprehensive solutions for quantitative evaluation and management of whole slide images. Their flagship platforms, HALO® and HALO AI, leverage artificial intelligence and computer vision algorithms to enable fast and precise analysis of tissue samples, which is critical for advancing research and […]
Triomics is an oncology AI company dedicated to transforming how cancer centers manage complex clinical information. The company’s platform utilizes AI agents to meticulously read and interpret comprehensive longitudinal patient records, converting unstructured clinical data—such as notes, pathology reports, imaging results, and genomic panels—into structured, verifiable outputs. This process significantly reduces the manual burden on […]
ClinTrialMatch is an AI-powered digital health platform designed to optimize patient recruitment, enrollment, and retention in clinical trials. The platform aims to bridge the gap between patients seeking treatment options and clinical trials needing participants by leveraging AI-driven insights. It is currently an early-stage platform undergoing development and pilot collaboration. For physicians, ClinTrialMatch offers a […]
Evaxion Biotech is a pioneering clinical-stage TechBio company that leverages its proprietary, clinically validated, and scalable AI platform, AI-Immunology™, to decode the human immune system. This platform is used to discover and develop novel immunotherapies for cancer, infectious diseases, and increasingly, autoimmune diseases. The company’s mission is to transform patients’ lives by providing inventive and […]

